Delayed-onset adenosine deaminase deficiency with a novel synonymous mutation and a case series from China

[1]  J. Kere,et al.  Characterization of Expanded Gamma Delta T Cells from Atypical X-SCID Patient Reveals Preserved Function and IL2RG-Mediated Signaling , 2022, Journal of Clinical Immunology.

[2]  L. Notarangelo,et al.  Outcomes Following Treatment for Adenosine Deaminase Deficient Severe Combined Immunodeficiency: A Report from the PIDTC. , 2022, Blood.

[3]  I. Aksentijevich,et al.  Mechanisms of vascular inflammation in deficiency of adenosine deaminase 2 (DADA2) , 2022, Seminars in Immunopathology.

[4]  C. Wouters,et al.  Intrinsic Defects in B Cell Development and Differentiation, T Cell Exhaustion and Altered Unconventional T Cell Generation Characterize Human Adenosine Deaminase Type 2 Deficiency , 2021, Journal of Clinical Immunology.

[5]  P. Marits,et al.  First Year of TREC-Based National SCID Screening in Sweden , 2021, International journal of neonatal screening.

[6]  I. Bottillo,et al.  Identification of seven exonic variants in the SLC4A1, ATP6V1B1, and ATP6V0A4 genes that alter RNA splicing by minigene assay , 2021, Human mutation.

[7]  Peng Liu,et al.  National Rare Diseases Registry System (NRDRS): China’s first nation-wide rare diseases demographic analyses , 2021, Orphanet Journal of Rare Diseases.

[8]  K. Cornetta,et al.  Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency. , 2021, The New England journal of medicine.

[9]  C. Shi,et al.  Dichotomous and stable gamma delta T-cell number and function in healthy individuals , 2021, Journal for ImmunoTherapy of Cancer.

[10]  A. Gennery,et al.  Adenosine Deaminase Deficient SCID with Myocardial Hypertrophy , 2021, Journal of Clinical Immunology.

[11]  S. Peña-Llopis,et al.  A BAP1 synonymous mutation results in exon skipping, loss of function and worse patient prognosis , 2021, iScience.

[12]  G. Marucci,et al.  Combined Therapy of A1AR Agonists and A2AAR Antagonists in Neuroinflammation , 2021, Molecules.

[13]  Lie Huang,et al.  Inhibition of A2B Adenosine Receptor Attenuates Intestinal Injury in a Rat Model of Necrotizing Enterocolitis , 2020, Mediators of inflammation.

[14]  D. Pellicci,et al.  Thymic development of unconventional T cells: how NKT cells, MAIT cells and γδ T cells emerge , 2020, Nature Reviews Immunology.

[15]  Mingjie Li,et al.  A synonymous mutation in exon 39 of FBN1 causes exon skipping leading to Marfan syndrome. , 2020, Genomics.

[16]  Junfeng Xia,et al.  Comparison and integration of computational methods for deleterious synonymous mutation prediction , 2020, Briefings Bioinform..

[17]  Chanjuan Hao,et al.  Whole‐exome sequencing reveals two de novo variants in the RBM20 gene in two Chinese patients with left ventricular non‐compaction cardiomyopathy , 2020, Pediatric investigation.

[18]  G. Damonte,et al.  Dysregulation in B‐cell responses and T follicular helper cell function in ADA2 deficiency patients , 2020, European journal of immunology.

[19]  P. Soler-Palacín,et al.  First Universal Newborn Screening Program for Severe Combined Immunodeficiency in Europe. Two-Years' Experience in Catalonia (Spain) , 2019, Front. Immunol..

[20]  L. Notarangelo,et al.  Increased proportions of γδ T lymphocytes in atypical SCID associate with disease manifestations. , 2019, Clinical immunology.

[21]  L. Notarangelo,et al.  Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency. , 2019, The Journal of allergy and clinical immunology.

[22]  J. Puck,et al.  Newborn Screening for Severe Combined Immunodeficiency and T-cell Lymphopenia in California, 2010–2017 , 2019, Pediatrics.

[23]  Anne Pham-Huy,et al.  Neutropenia among patients with adenosine deaminase deficiency. , 2019, The Journal of allergy and clinical immunology.

[24]  M. Rimbert,et al.  Newborn Screening for Severe Combined Immunodeficiency: Analytic and Clinical Performance of the T Cell Receptor Excision Circle Assay in France (DEPISTREC Study) , 2018, Journal of Clinical Immunology.

[25]  I. Meyts,et al.  Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment , 2018, Journal of Clinical Immunology.

[26]  O. Sanal,et al.  ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome , 2018, Journal of Clinical Immunology.

[27]  A. Gennery,et al.  Adenosine deaminase deficiency: a review , 2018, Orphanet Journal of Rare Diseases.

[28]  E. Torun,et al.  A case of severe combined immunodeficiency caused by adenosine deaminase deficiency with a new mutation. , 2017, Pediatrics and neonatology.

[29]  Parth N. Patel,et al.  Identification of pathogenic gene mutations in LMNA and MYBPC3 that alter RNA splicing , 2017, Proceedings of the National Academy of Sciences.

[30]  K. Varani,et al.  A2B adenosine receptors stimulate IL‐6 production in primary murine microglia through p38 MAPK kinase pathway , 2017, Pharmacological research.

[31]  A. Zavialov,et al.  Human adenosine deaminases ADA1 and ADA2 bind to different subsets of immune cells , 2017, Cellular and Molecular Life Sciences.

[32]  L. Leocani,et al.  Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patients , 2017, Scientific Reports.

[33]  Joanne M. Smart,et al.  Adenosine Deaminase Deficient Severe Combined Immunodeficiency Presenting as Atypical Haemolytic Uraemic Syndrome , 2015, Journal of Clinical Immunology.

[34]  E. Kókai,et al.  Adenosine and inflammation: what's new on the horizon? , 2014, Drug discovery today.

[35]  Chava Kimchi-Sarfaty,et al.  Exposing synonymous mutations. , 2014, Trends in genetics : TIG.

[36]  E. López-Granados,et al.  Enrichment of the rare CD4⁺ γδ T-cell subset in patients with atypical CD3δ deficiency. , 2014, The Journal of allergy and clinical immunology.

[37]  J. Mullikin,et al.  Early-onset stroke and vasculopathy associated with mutations in ADA2. , 2014, The New England journal of medicine.

[38]  T. Walsh,et al.  Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. , 2014, The New England journal of medicine.

[39]  Y. Lau,et al.  γδ-T cells: an unpolished sword in human anti-infection immunity , 2012, Cellular and Molecular Immunology.

[40]  A. Aiuti,et al.  Autoimmune Dysregulation and Purine Metabolism in Adenosine Deaminase Deficiency , 2012, Front. Immun..

[41]  T. Blackwell,et al.  The A2B adenosine receptor modulates pulmonary hypertension associated with interstitial lung disease , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  O. Ohara,et al.  Delayed onset adenosine deaminase deficiency associated with acute disseminated encephalomyelitis , 2012, International Journal of Hematology.

[43]  S. Pittaluga,et al.  Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiency. , 2012, The Journal of allergy and clinical immunology.

[44]  H. Gaspar,et al.  Non-infectious Lung Disease in Patients with Adenosine Deaminase Deficient Severe Combined Immunodeficiency , 2012, Journal of Clinical Immunology.

[45]  D. Kohn,et al.  A Tale of Two SCIDs , 2011, Science Translational Medicine.

[46]  K. Schwarz,et al.  Hyperbilirubinemia and Rapid Fatal Hepatic Failure in Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency (ADA-SCID) , 2011, Klinische Padiatrie.

[47]  A. Butte,et al.  Non-Synonymous and Synonymous Coding SNPs Show Similar Likelihood and Effect Size of Human Disease Association , 2010, PloS one.

[48]  H. Gaspar.  Bone marrow transplantation and alternatives for adenosine deaminase deficiency. , 2010, Immunology and allergy clinics of North America.

[49]  M. Roncarolo,et al.  ADA-deficient SCID is associated with a specific microenvironment and bone phenotype characterized by RANKL/OPG imbalance and osteoblast insufficiency. , 2009, Blood.

[50]  D. Carbone,et al.  Adenosine receptors in regulation of dendritic cell differentiation and function. , 2008, Blood.

[51]  H. Gaspar,et al.  Bilateral sensorineural deafness in adenosine deaminase-deficient severe combined immunodeficiency. , 2004, The Journal of pediatrics.

[52]  M. Aldrich,et al.  Impaired Germinal Center Maturation in Adenosine Deaminase Deficiency1 , 2003, The Journal of Immunology.

[53]  M. Sitkovsky,et al.  Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling. , 2001, Journal of Clinical Investigation.

[54]  Sara G. Becker-Catania,et al.  Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences. , 1999, American journal of human genetics.

[55]  T. Kepler,et al.  Nucleotide pool imbalance and adenosine deaminase deficiency induce alterations of N-region insertions during V(D)J recombination. , 1999, The Journal of clinical investigation.

[56]  F. Arredondo-Vega,et al.  Adenosine deaminase deficiency: genotype-phenotype correlations based on expressed activity of 29 mutant alleles. , 1998, American journal of human genetics.

[57]  K. Weinberg,et al.  Three new adenosine deaminase mutations that define a splicing enhancer and cause severe and partial phenotypes: implications for evolution of a CpG hotspot and expression of a transduced ADA cDNA. , 1995, Human molecular genetics.

[58]  W. Zhu,et al.  Interference with thymocyte differentiation by an inhibitor of S-adenosylhomocysteine hydrolase. , 1995, Journal of immunology.

[59]  R. Hirschhorn,et al.  Identification of a point mutation resulting in a heat-labile adenosine deaminase (ADA) in two unrelated children with partial ADA deficiency. , 1989, The Journal of clinical investigation.

[60]  E. Giblett,et al.  Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. , 1972, Lancet.

[61]  Y. Chien,et al.  Incidence of severe combined immunodeficiency through newborn screening in a Chinese population. , 2015, Journal of the Formosan Medical Association = Taiwan yi zhi.

[62]  U. Pannicke,et al.  A variant of SCID with specific immune responses and predominance of gamma delta T cells. , 2005, The Journal of clinical investigation.

[63]  R. Hirschhorn.  Adenosine deaminase deficiency. , 1987, Hospital practice.